Characterization of subcutaneous Contramid® implantation: Host response and delivery of a potent analog of the growth hormone-releasing factor

International Journal of Pharmaceutics

Volumn 232, Issue 1-2, 2002, Pages 119-129

  Désévaux, Cyril ^a,b   Girard, Christiane ^a   Lenaerts, Vincent ^b   Dubreuil, Pascal ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Labopharm Inc   (Canada)

Author keywords

Biocompatibility; Controlled release; Cross linked starch; GRF; Implant

Indexed keywords

AMYLOSE; CONTRAMID; GROWTH HORMONE RELEASING FACTOR; STARCH; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG IMPLANT; DRUG IMPLANTATION; DRUG POTENCY; DRUG TOLERANCE; IMMUNE RESPONSE; IMPLANTABLE PORT SYSTEM; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SWINE;

ANIMALS; BIOCOMPATIBLE MATERIALS; CROSS-LINKING REAGENTS; DRUG IMPLANTS; GROWTH HORMONE-RELEASING HORMONE; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; MACROPHAGES; MICE; STARCH; SWINE;

EID: 0037203661     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00912-7     Document Type: Article

References (41)

1. Insulin-like growth factor-I concentration in Holstein female cattle: Variations with age, stage of lactation and growth hormone-releasing factor administration
2. Inflammation and the foreign body response
3. Biomaterial biocompatibilty and the macrophage
4. Biodegradable microspheres I: Duration of action of dextranase entrapped in polyacrylstarch microparticles in vivo
5. Biodegradable microspheres V: Stimulation of macrophages with microparticles made of various polysaccharides
6. Macrophage stimulation with some structurally related polysaccharides
7. Degradable starch microspheres as a nasal delivery system for insulin
8. Characterization of degradable starch microspheres as a nasal delivery system for drugs
9. Morphologic examination of rabbit nasal mucosa after nasal administration of degradable starch microspheres
10. Evaluation of starch-maltodextrin-Carbopol® 974 P mixtures for nasal delivery of insulin in rabbits
11. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men
12. Human growth hormone and human aging
13. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men
14. Improved regional selectivity of hepatic arterial BCNU with degradable microspheres
15. Influence of age and sex on basal secretion of growth hormone (GH) and on GH-induced release by porcine GH-releasing factor pGRF(1-29)NH2 in growing pigs
16. Effect of dose and frequency of administration of a potent analog of growth hormone-releasing factor on hormone secretion and growth in pigs
17. Effect of growth hormone-releasing factor infusion on somatotropin, prolactin, thyroxine, insulin, insulin-like growth factor I and blood metabolites in control and somatostatin-immunized growing pigs
18. Somatotropin delivery to farmed animals
19. Transient blood flow reduction induced by intra-arterial injection of degradable starch microspheres
20. Histologic reactions to polyglactin-910, polyethylene and nylon microsuture
21. Nasal administration of gentamicin using novel microsphere delivery system
22. Growth performance, carcass characteristics, and sensory attributes of boars administered porcine somatotropin by sustained-release implant for different lengths of time
23. Growth, body composition, and endocrine responses to chronic administration of insulin-like growth factor I and(or) porcine growth hormone in pigs
24. Ghrelin is a novel growth-hormone-releasing acylated peptide from stomach
25. Biodegradable microspheres IV: Factors affecting the distribution and degradation of polyacryl starch microparticles
26. New methods of drug delivery
27. Controlled release of theophylline from cross-linked amylose tablets
28. Cross-linked high amylose starch for controlled release of drugs: Recent advances
29. Evaluation of soft tissue response to a poly(urethane urea)
30. Characterization of moving fronts in cross-linked amylose matrices by image analysis
31. Image analysis studies of water transport and dimensional changes occurring in the early stages of hydration in cross-linked amylose matrices
32. Adhesion formation and histologic reaction with polydioxanone and polyglactin suture
33. Hormone containing growth promoting implants in farmed livestock
34. Enzymatic degradation of cross-linked high amylose starch tablets and its effect on in vitro release of sodium diclofenac
35. The effects of porosity on endothelialization of ePTFE implanted in subcutaneous and adipose tissue
36. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties
37. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties
38. Interrelationship of somatostatin and growth hormone-releasing hormone in the genesis of the rhythmic secretion of growth hormone
39. Biodegradable microspheres as a delivery system for rismorelin porcine, a porcine-growth-hormone-releasing-hormone
40. Inflammation
41. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and GH-deficient boy